General Archives - Page 2336 of 2367

2 minute read

ABVC BioPharma Provides ADHD Phase II Part 2 Clinical Update

July 13, 8:33 AM

via NewMediaWire – ABVC Biopharma, Inc. (NASDAQ:ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology, today announced the

ABVC

1 minute read

Comera Life Sciences Announces Preclinical Topline Safety Results Of Lead SQore Excipient

By Benzinga Newsdesk

July 13, 8:07 AM

Comera Life Sciences Announces Favorable Preclinical Topline Safety Results of Lead SQore Excipient

CMRA

1 minute read

General
News

Snapchat Parent Mulls NFT Access For Users

By Shivani Kumaresan

July 13, 7:54 AM

Snap Inc (NYSE:SNAP) is planning to allow users to showcase non-fungible tokens (NFTs) on its application, the Financial Times reported.…

Humanigen’s Lenzilumab Disappoints In NIH-Backed COVID-19 Study

By Vandana Singh

July 13, 7:39 AM

Humanigen Inc (NASDAQ: HGEN) has been informed of preliminary topline results from the ACTIV-5/BET-B trial evaluating lenzilumab plus remdesivir versus placebo plus remdesivir in hospitalized COVID-19 patients.

HGEN

1 minute read

Enveric Biosciences Advances Drug Development For Mental Health Indications And Intellectual Property Portfolio

By Benzinga Newsdesk

July 13, 7:30 AM

-- Advancing to IND-enabling studies with multiple drug candidates -- -- Enveric’s Growing Patent Portfolio Validated --

ENVB

1 minute read

Endo Weighing Chapter 11 Filing Before Junior Creditors, Opioid Settlements: Report

By Vandana Singh

July 13, 6:34 AM

Endo International Plc (NASDAQ:ENDP) is considering bankruptcy filing to restructure its more than $8 billion of debt and several…

ENDP

2 minute read

Pluristem Reports Topline Results From Its Phase III Study Of Muscle Regeneration Following Hip Fracture Surgery

By Benzinga Newsdesk

July 13, 6:02 AM

Pluristem Therapeutics Inc. (NASDAQ:PSTI) (TASE:PSTI) (“Pluristem” or the “Company”), a leading biotechnology company, today announced topline results from its multinational double-blind,

PSTI

2 minute read

Elon Musk A ‘Sloppy’ ‘Idiot’ On Drugs — Trump Was Bashing Tesla CEO In Private Long Before 1st Public Vent

By Shivdeep Dhaliwal

July 13, 3:00 AM

Tesla Inc (NASDAQ: TSLA) CEO Elon Musk was being criticized by former President Donald Trump privately since April, much before the condemnation turned public.

TSLA

2 minute read

Elon Musk Vs Twitter In Court: Analyst Says Brace Yourself For A ‘Game Of Thrones’ Style Battle

By Shivdeep Dhaliwal

July 12, 11:14 PM

Twitter Inc (NYSE: TWTR) has a “strong iron fist upper hand” in the legal fight set to play out in a Delaware court after Tesla Inc (NASDAQ: TSLA) CEO Elon Musk said he was terminating a deal

TSLA

2 minute read

NFTs Head To The Upside Down: How You Can Get ‘Stranger Things’ NFTs

By Chris Katje

July 12, 7:25 PM

A leading digital collectibles company is headed to the Upside Down to bring to consumers NFTs based on one of the most popular television shows.

ETH